Friday - March 08, 2019 Bayer publishes Gender Pay Gap Report At Bayer, gender pay forms part of a wider diversity and inclusion commitment, which also includes ethnicity, disability and LGBT+. more
Friday - March 08, 2019 2018/19 Ophthalmology Honours results announced Bayer’s Ophthalmology Honours programme acknowledges excellent work by multi-disciplinary ophthalmology teams throughout the UK more
Wednesday - February 27, 2019 Bayer increases sales and earnings – leader in agriculture after acquisition Group sales advance 4.5 percent (Fx & portfolio adj.) to 39.586 billion euros / EBITDA before special items increases by 2.8 percent to 9.547 billion euros, held back by currency effects of 457 million euros / Pharmaceuticals posts higher sales (Fx & portfolio adj.) and slightly lower earnings / Consumer Health: sales level with prior year (Fx & portfolio adj.), earnings decline / Crop Science reports sales gains, substantially higher earnings due to the acquisition, integration off to a strong start / Positive safety profile of glyphosate unchanged – Bayer vigorously defending itself against lawsuits/ Net income at 1.695 billion euros, impacted by one-time effects / Core earnings per share at 5.94 euros, above expectations / Net financial debt at 35.679 billion euros, significantly better than expected / Bayer confirms 2019 Group outlook and 2022 targets more
Advancing Together: Bayer to Acquire Monsanto The acquisition realizes the joint vision of integrated agricultural offering delivering superior solutions for growers and creates an innovation powerhouse for the next generation of farming. more
